Emerging Biotech
Clinical Operations Strategies for
Faster Trials and Better Oversight
Implement a holistic and efficient oversight approach, regardless of your outsourcing model.
80%
faster identification of and reaction to trial issues
20%
reduction in training budget with better outcomes
70%
reduction in start-up document exchange
Blog
Beyond the Tracker: Gaining Oversight and Improving Quality in Outsourced Trials
Scaling biotechs and CROs are evolving beyond trackers for effective trial oversight. Hear from Immunovant and Precision for Medicine on their strategies for unifying data, technology, and partnerships.
“To be able to have our own systems gives us the ultimate control. This has allowed us to streamline processes, reduce errors, and improve overall efficiency, which is crucial for scaling our operations as we grow.”
Bonne Adams
Vice President Operations, Inhibrx Biosciences, Inc.
“More oversight is a change of mindset for sponsors and CROs. We need to invest in a continuous oversight improvement process, which is not a nice-to-have but a must in light of ICH E6(R3).”
Luca Manfro
Global R&D digital solutions manager, Recordati
“With Veeva CTMS and eTMF, we have a platform that works across the entire company with seamless integration.”
John McAdory
Vice President, Clinical Operations, CG Oncology
Industry Insights
See how clinical operations leaders
improve visibility, control, and efficiency
Maximize Operational Efficiency
Drive trial efficiency and ensure oversight regardless of operating model.
Ensure Compliance
Be proactive, rather than reactive, by developing an inspection-ready culture.
Improve Site Engagement
Empower sites, reduce burden, and improve collaboration for faster, higher-quality trials.
